NIF-1 inhibitors are a class of chemical compounds designed to selectively interfere with the activity of nuclear factor I (NIF-1), a DNA-binding protein involved in the regulation of gene transcription. NIF-1 belongs to a family of proteins that function as transcription factors, playing a critical role in regulating the expression of genes involved in cellular differentiation, replication, and other essential cellular processes. The inhibition of NIF-1 activity is achieved by compounds that either prevent the protein from binding to its DNA targets or disrupt its interaction with other proteins that facilitate transcriptional regulation. This can lead to changes in gene expression patterns that are relevant to a variety of biological processes.
The structural diversity of NIF-1 inhibitors varies significantly, with many compounds featuring specific molecular frameworks designed to optimize their binding to the NIF-1 protein or its DNA binding domain. These compounds may work by allosterically modifying the protein's structure or by directly blocking its ability to interact with DNA. The precise mechanism of action often depends on the specific inhibitor, but they are typically designed to exhibit high specificity for NIF-1 to minimize off-target effects on other transcription factors. These inhibitors are valuable tools for studying the molecular mechanisms of gene regulation, particularly in understanding how NIF-1 controls the expression of specific genes and their roles in various cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression patterns regulated by ZNF335. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase (HDAC) inhibitor, which can alter chromatin structure and gene expression, potentially impacting ZNF335-regulated genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another HDAC inhibitor, potentially influencing the transcriptional regulation activities of ZNF335. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor, potentially affecting DNA methylation and gene expression regulated by ZNF335. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, used to reactivate silenced genes, which might influence ZNF335-regulated pathways. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor with neuroprotective and neurogenic effects, potentially affecting ZNF335-related pathways. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
An HDAC inhibitor, potentially modulating gene expression patterns relevant to ZNF335 function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor, potentially affecting gene expression regulated by ZNF335. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
An HDAC inhibitor, potentially influencing chromatin remodeling and gene expression relevant to ZNF335. | ||||||
SGI-1027 | 1020149-73-8 | sc-473875 | 10 mg | $213.00 | ||
A DNA methyltransferase inhibitor, potentially affecting the epigenetic regulation of genes associated with ZNF335. | ||||||